Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Novel multitarget 5-arylidenehydantoins with arylpiperazinealkyl fragment: Pharmacological evaluation and investigation of cytotoxicity and metabolic stability.

Czopek A, Bucki A, Kołaczkowski M, Zagórska A, Drop M, Pawłowski M, Siwek A, Głuch-Lutwin M, Pękala E, Chrzanowska A, Struga M, Partyka A, Wesołowska A.

Bioorg Med Chem. 2019 Jul 30. pii: S0968-0896(19)30639-X. doi: 10.1016/j.bmc.2019.07.046. [Epub ahead of print]

PMID:
31383628
2.

Low-dimensional perovskite nanoplatelet synthesis using in situ photophysical monitoring to establish controlled growth.

Do M, Kim I, Kolaczkowski MA, Kang J, Kamat GA, Yuan Z, Barchi NS, Wang LW, Liu Y, Jurow MJ, Sutter-Fella CM.

Nanoscale. 2019 Jun 27. doi: 10.1039/c9nr04010b. [Epub ahead of print]

PMID:
31246216
3.

Anti-Alzheimer's multitarget-directed ligands with serotonin 5-HT6 antagonist, butyrylcholinesterase inhibitory, and antioxidant activity.

Marcinkowska M, Bucki A, Panek D, Siwek A, Fajkis N, Bednarski M, Zygmunt M, Godyń J, Del Rio Valdivieso A, Kotańska M, Kołaczkowski M, Więckowska A.

Arch Pharm (Weinheim). 2019 Jul;352(7):e1900041. doi: 10.1002/ardp.201900041. Epub 2019 Jun 4.

PMID:
31162703
4.

Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT1A Receptor-Biased Agonists with Robust Antidepressant-like Activity.

Sniecikowska J, Gluch-Lutwin M, Bucki A, Więckowska A, Siwek A, Jastrzebska-Wiesek M, Partyka A, Wilczyńska D, Pytka K, Pociecha K, Cios A, Wyska E, Wesołowska A, Pawłowski M, Varney MA, Newman-Tancredi A, Kolaczkowski M.

J Med Chem. 2019 Mar 14;62(5):2750-2771. doi: 10.1021/acs.jmedchem.9b00062. Epub 2019 Mar 2.

PMID:
30721053
5.

Functional Organic Semiconductors Based on Bay-Annulated Indigo (BAI).

Kolaczkowski MA, Liu Y.

Chem Rec. 2019 Jun;19(6):1062-1077. doi: 10.1002/tcr.201800159. Epub 2019 Jan 21. Review.

PMID:
30663204
6.

Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells - The involvement of carbonyl reductase 1 inhibition.

Piska K, Koczurkiewicz P, Wnuk D, Karnas E, Bucki A, Wójcik-Pszczoła K, Jamrozik M, Michalik M, Kołaczkowski M, Pękala E.

Chem Biol Interact. 2019 Feb 25;300:40-48. doi: 10.1016/j.cbi.2019.01.003. Epub 2019 Jan 3.

PMID:
30611789
7.

Characteristics of metabolic stability and the cell permeability of 2-pyrimidinyl-piperazinyl-alkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione with antidepressant- and anxiolytic-like activities.

Zagórska A, Partyka A, Bucki A, Kołaczkowski M, Jastrzębska-Więsek M, Czopek A, Siwek A, Głuch-Lutwin M, Bednarski M, Bajda M, Jończyk J, Piska K, Koczurkiewicz P, Wesołowska A, Pawłowski M.

Chem Biol Drug Des. 2019 Apr;93(4):511-521. doi: 10.1111/cbdd.13442. Epub 2018 Dec 4.

PMID:
30422400
8.

HBK-17, a 5-HT1A Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin Signaling.

Pytka K, Głuch-Lutwin M, Żmudzka E, Sałaciak K, Siwek A, Niemczyk K, Walczak M, Smolik M, Olczyk A, Gałuszka A, Śmieja J, Filipek B, Sapa J, Kołaczkowski M, Pańczyk K, Waszkielewicz A, Marona H.

Front Pharmacol. 2018 Oct 16;9:1146. doi: 10.3389/fphar.2018.01146. eCollection 2018.

9.

Multifunctional arylsulfonamide derivatives with 5-HT6/5-HT7 receptor antagonistic activity: a structural study.

Kalinowska-Tłuścik J, Piaskowska A, Kołaczkowski M.

Acta Crystallogr C Struct Chem. 2018 Nov 1;74(Pt 11):1477-1486. doi: 10.1107/S2053229618013748. Epub 2018 Oct 23.

PMID:
30398204
10.

A Review of Probiotic Supplementation and Feasibility of Topical Application for the Treatment of Pediatric Atopic Dermatitis.

Marcinkowska M, Zagórska A, Fajkis N, Kołaczkowski M, Paśko P.

Curr Pharm Biotechnol. 2018;19(10):827-838. doi: 10.2174/1389201019666181008113149. Review.

PMID:
30317995
11.

Novel antagonists of 5-HT6 and/or 5-HT7 receptors affect the brain monoamines metabolism and enhance the anti-immobility activity of different antidepressants in rats.

Partyka A, Jastrzębska-Więsek M, Antkiewicz-Michaluk L, Michaluk J, Wąsik A, Canale V, Zajdel P, Kołaczkowski M, Wesołowska A.

Behav Brain Res. 2019 Feb 1;359:9-16. doi: 10.1016/j.bbr.2018.10.004. Epub 2018 Oct 9.

PMID:
30312638
12.

Chronic antidepressant-like effect of EMD386088, a partial 5-HT6 receptor agonist, in olfactory bulbectomy model may be connected with BDNF and/or CREB signalling pathway.

Jastrzębska-Więsek M, Gdula-Argasińska J, Siwek A, Partyka A, Szewczyk B, Kołaczkowski M, Wesołowska A.

Pharmacol Rep. 2018 Dec;70(6):1047-1056. doi: 10.1016/j.pharep.2018.05.009. Epub 2018 May 24.

PMID:
30292720
13.

Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.

Chłoń-Rzepa G, Ślusarczyk M, Jankowska A, Gawalska A, Bucki A, Kołaczkowski M, Świerczek A, Pociecha K, Wyska E, Zygmunt M, Kazek G, Sałat K, Pawłowski M.

Eur J Med Chem. 2018 Oct 5;158:517-533. doi: 10.1016/j.ejmech.2018.09.021. Epub 2018 Sep 10.

PMID:
30245393
14.

Synthesis and activity of di- or trisubstituted N-(phenoxyalkyl)- or N-{2-[2-(phenoxy)ethoxy]ethyl}piperazine derivatives on the central nervous system.

Pańczyk K, Pytka K, Jakubczyk M, Rapacz A, Sałat K, Furgała A, Siwek A, Głuch-Lutwin M, Gryboś A, Słoczyńska K, Pękala E, Żmudzki P, Bucki A, Kołaczkowski M, Żelaszczyk D, Marona H, Waszkielewicz AM.

Bioorg Med Chem Lett. 2018 Jun 15;28(11):2039-2049. doi: 10.1016/j.bmcl.2018.04.059. Epub 2018 Apr 25.

PMID:
29730027
15.

The preclinical discovery and development of cariprazine for the treatment of schizophrenia.

Wesołowska A, Partyka A, Jastrzębska-Więsek M, Kołaczkowski M.

Expert Opin Drug Discov. 2018 Aug;13(8):779-790. doi: 10.1080/17460441.2018.1471057. Epub 2018 May 3. Review.

PMID:
29722587
16.

Synthesis and biological evaluation of N-arylpiperazine derivatives of 4,4-dimethylisoquinoline-1,3(2H,4H)-dione as potential antiplatelet agents.

Marcinkowska M, Kotańska M, Zagórska A, Śniecikowska J, Kubacka M, Siwek A, Bucki A, Pawłowski M, Bednarski M, Sapa J, Starek M, Dąbrowska M, Kołaczkowski M.

J Enzyme Inhib Med Chem. 2018 Dec;33(1):536-545. doi: 10.1080/14756366.2018.1437155.

17.

Novel butanehydrazide derivatives of purine-2,6-dione as dual PDE4/7 inhibitors with potential anti-inflammatory activity: Design, synthesis and biological evaluation.

Chłoń-Rzepa G, Jankowska A, Ślusarczyk M, Świerczek A, Pociecha K, Wyska E, Bucki A, Gawalska A, Kołaczkowski M, Pawłowski M.

Eur J Med Chem. 2018 Feb 25;146:381-394. doi: 10.1016/j.ejmech.2018.01.068. Epub 2018 Feb 4.

PMID:
29407965
18.

Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer's Disease.

Więckowska A, Wichur T, Godyń J, Bucki A, Marcinkowska M, Siwek A, Więckowski K, Zaręba P, Knez D, Głuch-Lutwin M, Kazek G, Latacz G, Mika K, Kołaczkowski M, Korabecny J, Soukup O, Benkova M, Kieć-Kononowicz K, Gobec S, Malawska B.

ACS Chem Neurosci. 2018 May 16;9(5):1195-1214. doi: 10.1021/acschemneuro.8b00024. Epub 2018 Feb 13.

PMID:
29384656
19.

Idalopirdine, a selective 5-HT6 receptor antagonist, reduces food intake and body weight in a model of excessive eating.

Kotańska M, Lustyk K, Bucki A, Marcinkowska M, Śniecikowska J, Kołaczkowski M.

Metab Brain Dis. 2018 Jun;33(3):733-740. doi: 10.1007/s11011-017-0175-1. Epub 2018 Jan 3.

20.

Activity of Serotonin 5-HT1A Receptor Biased Agonists in Rat: Anxiolytic and Antidepressant-like properties.

Jastrzębska-Więsek M, Partyka A, Rychtyk J, Śniecikowska J, Kołaczkowski M, Wesołowska A, Varney MA, Newman-Tancredi A.

ACS Chem Neurosci. 2018 May 16;9(5):1040-1050. doi: 10.1021/acschemneuro.7b00443. Epub 2018 Jan 11.

PMID:
29266914
21.

Novel and effective synthesis protocol of AgNPs functionalized using L-cysteine as a potential drug carrier.

Wojnicki M, Luty-Błocho M, Kotańska M, Wytrwal M, Tokarski T, Krupa A, Kołaczkowski M, Bucki A, Kobielusz M.

Naunyn Schmiedebergs Arch Pharmacol. 2018 Feb;391(2):123-130. doi: 10.1007/s00210-017-1440-x. Epub 2017 Nov 16.

22.

Study on the effect of EMD386088, a 5-HT6 receptor partial agonist, in enhancing the anti-immobility action of some antidepressants in rats.

Jastrzębska-Więsek M, Siwek A, Partyka A, Kołaczkowski M, Walczak M, Smolik M, Latacz G, Kieć-Kononowicz K, Wesołowska A.

Naunyn Schmiedebergs Arch Pharmacol. 2018 Jan;391(1):37-49. doi: 10.1007/s00210-017-1431-y. Epub 2017 Oct 27.

23.

Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity.

Bucki A, Marcinkowska M, Śniecikowska J, Więckowski K, Pawłowski M, Głuch-Lutwin M, Gryboś A, Siwek A, Pytka K, Jastrzębska-Więsek M, Partyka A, Wesołowska A, Mierzejewski P, Kołaczkowski M.

J Med Chem. 2017 Sep 14;60(17):7483-7501. doi: 10.1021/acs.jmedchem.7b00839. Epub 2017 Aug 18.

PMID:
28763213
24.

Antinociceptive, antiallodynic and antihyperalgesic effects of the 5-HT1A receptor selective agonist, NLX-112 in mouse models of pain.

Sałat K, Kołaczkowski M, Furgała A, Rojek A, Śniecikowska J, Varney MA, Newman-Tancredi A.

Neuropharmacology. 2017 Oct;125:181-188. doi: 10.1016/j.neuropharm.2017.07.022. Epub 2017 Jul 24.

PMID:
28751195
25.

Preventing Thin Film Dewetting via Graphene Capping.

Cao P, Bai P, Omrani AA, Xiao Y, Meaker KL, Tsai HZ, Yan A, Jung HS, Khajeh R, Rodgers GF, Kim Y, Aikawa AS, Kolaczkowski MA, Liu Y, Zettl A, Xu K, Crommie MF, Xu T.

Adv Mater. 2017 Sep;29(36). doi: 10.1002/adma.201701536. Epub 2017 Jul 19.

PMID:
28722188
26.

para-Azaquinodimethane: A Compact Quinodimethane Variant as an Ambient Stable Building Block for High-Performance Low Band Gap Polymers.

Liu X, He B, Anderson CL, Kang J, Chen T, Chen J, Feng S, Zhang L, Kolaczkowski MA, Teat SJ, Brady MA, Zhu C, Wang LW, Chen J, Liu Y.

J Am Chem Soc. 2017 Jun 21;139(24):8355-8363. doi: 10.1021/jacs.7b04031. Epub 2017 Jun 6.

PMID:
28537070
27.

Metabolic carbonyl reduction of anthracyclines - role in cardiotoxicity and cancer resistance. Reducing enzymes as putative targets for novel cardioprotective and chemosensitizing agents.

Piska K, Koczurkiewicz P, Bucki A, Wójcik-Pszczoła K, Kołaczkowski M, Pękala E.

Invest New Drugs. 2017 Jun;35(3):375-385. doi: 10.1007/s10637-017-0443-2. Epub 2017 Mar 10. Review.

28.

Metabolic and Cardiovascular Benefits and Risks of EMD386088-A 5-HT6 Receptor Partial Agonist and Dopamine Transporter Inhibitor.

Kotańska M, Śniecikowska J, Jastrzębska-Więsek M, Kołaczkowski M, Pytka K.

Front Neurosci. 2017 Feb 8;11:50. doi: 10.3389/fnins.2017.00050. eCollection 2017.

29.

3-Aminomethyl Derivatives of 2-Phenylimidazo[1,2-a]-pyridine as Positive Allosteric Modulators of GABAA Receptor with Potential Antipsychotic Activity.

Marcinkowska M, Kołaczkowski M, Kamiński K, Bucki A, Pawłowski M, Siwek A, Karcz T, Starowicz G, Słoczyńska K, Pękala E, Wesołowska A, Samochowiec J, Mierzejewski P, Bienkowski P.

ACS Chem Neurosci. 2017 Jun 21;8(6):1291-1298. doi: 10.1021/acschemneuro.6b00432. Epub 2017 Mar 1.

PMID:
28211669
30.

Aminoalkyl Derivatives of 8-Alkoxypurine-2,6-diones: Multifunctional 5-HT1A /5-HT7 Receptor Ligands and PDE Inhibitors with Antidepressant Activity.

Chłoń-Rzepa G, Zagórska A, Żmudzki P, Bucki A, Kołaczkowski M, Partyka A, Wesołowska A, Kazek G, Głuch-Lutwin M, Siwek A, Starowicz G, Pawłowski M.

Arch Pharm (Weinheim). 2016 Dec;349(12):889-903. doi: 10.1002/ardp.201600260. Epub 2016 Nov 21.

PMID:
27869315
31.

NEW SPIROHYDANTOIN DERIVATIVES - SYNTHESIS, PHARMACOLOGICAL EVALUATION, AND MOLECULAR MODELING STUDY.

Czopek A, Zagorska A, Kolaczkowski M, Bucki A, Gryzlo B, Rychtyk J, Pawlowsk M, Siwek A, Satala G, Bojarski A, Kubacka M, Filipek B.

Acta Pol Pharm. 2016 Nov;73(6):1545-1554.

PMID:
29634109
32.

Stepwise Bay Annulation of Indigo for the Synthesis of Desymmetrized Electron Acceptors and Donor-Acceptor Constructs.

Kolaczkowski MA, He B, Liu Y.

Org Lett. 2016 Oct 21;18(20):5224-5227. doi: 10.1021/acs.orglett.6b02504. Epub 2016 Oct 10.

33.

Design, synthesis, and biological evaluation of fluorinated imidazo[1,2-a]pyridine derivatives with potential antipsychotic activity.

Marcinkowska M, Kołaczkowski M, Kamiński K, Bucki A, Pawłowski M, Siwek A, Karcz T, Mordyl B, Starowicz G, Kubowicz P, Pękala E, Wesołowska A, Samochowiec J, Mierzejewski P, Bienkowski P.

Eur J Med Chem. 2016 Nov 29;124:456-467. doi: 10.1016/j.ejmech.2016.08.059. Epub 2016 Aug 26.

PMID:
27598234
34.

Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation.

Więckowska A, Kołaczkowski M, Bucki A, Godyń J, Marcinkowska M, Więckowski K, Zaręba P, Siwek A, Kazek G, Głuch-Lutwin M, Mierzejewski P, Bienkowski P, Sienkiewicz-Jarosz H, Knez D, Wichur T, Gobec S, Malawska B.

Eur J Med Chem. 2016 Nov 29;124:63-81. doi: 10.1016/j.ejmech.2016.08.016. Epub 2016 Aug 11.

PMID:
27560283
35.

Synthesis and biological evaluation of 2-fluoro and 3-trifluoromethyl-phenyl-piperazinylalkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione as potential antidepressant agents.

Zagórska A, Bucki A, Kołaczkowski M, Siwek A, Głuch-Lutwin M, Starowicz G, Kazek G, Partyka A, Wesołowska A, Słoczyńska K, Pękala E, Pawłowski M.

J Enzyme Inhib Med Chem. 2016;31(sup3):10-24. Epub 2016 Jun 29.

PMID:
27353547
36.

Rational tuning of high-energy visible light absorption for panchromatic small molecules by a two-dimensional conjugation approach.

He B, Zherebetskyy D, Wang H, Kolaczkowski MA, Klivansky LM, Tan T, Wang L, Liu Y.

Chem Sci. 2016 Jun 1;7(6):3857-3861. doi: 10.1039/c6sc00428h. Epub 2016 Feb 29.

37.

H3 histamine receptor antagonist pitolisant reverses some subchronic disturbances induced by olanzapine in mice.

Dudek M, Kuder K, Kołaczkowski M, Olczyk A, Żmudzka E, Rak A, Bednarski M, Pytka K, Sapa J, Kieć-Kononowicz K.

Metab Brain Dis. 2016 Oct;31(5):1023-9. doi: 10.1007/s11011-016-9840-z. Epub 2016 May 24.

38.

Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.

Jastrzębska-Więsek M, Siwek A, Partyka A, Antkiewicz-Michaluk L, Michaluk J, Romańska I, Kołaczkowski M, Wesołowska A.

Naunyn Schmiedebergs Arch Pharmacol. 2016 Aug;389(8):839-49. doi: 10.1007/s00210-016-1245-3. Epub 2016 Apr 23.

39.

ADN-1184, a monoaminergic ligand with 5-HT6/7 receptor antagonist action, exhibits activity in animal models of anxiety.

Partyka A, Wasik A, Jastrzębska-Więsek M, Mierzejewski P, Bieńkowski P, Kołaczkowski M, Wesołowska A.

Naunyn Schmiedebergs Arch Pharmacol. 2016 Jun;389(6):593-602. doi: 10.1007/s00210-016-1229-3. Epub 2016 Mar 16.

40.

Synthesis and Pharmacological Activity of a New Series of 1-(1H-Indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol Analogs.

Bednarski M, Otto M, Dudek M, Kołaczkowski M, Bucki A, Siwek A, Groszek G, Maziarz E, Wilk P, Sapa J.

Arch Pharm (Weinheim). 2016 Mar;349(3):211-23. doi: 10.1002/ardp.201500234. Epub 2016 Feb 8.

PMID:
26853441
41.

Antipsychotic-like effects of zolpidem in Wistar rats.

Mierzejewski P, Kolaczkowski M, Marcinkowska M, Wesolowska A, Samochowiec J, Pawlowski M, Bienkowski P.

Eur J Pharmacol. 2016 Feb 15;773:51-8. doi: 10.1016/j.ejphar.2016.01.009. Epub 2016 Jan 26.

PMID:
26825544
42.

Drug resistance mechanisms and their regulation in non-albicans Candida species.

Kołaczkowska A, Kołaczkowski M.

J Antimicrob Chemother. 2016 Jun;71(6):1438-50. doi: 10.1093/jac/dkv445. Epub 2016 Jan 21. Review.

PMID:
26801081
43.

Idalopirdine - a small molecule antagonist of 5-HT6 with therapeutic potential against obesity.

Dudek M, Marcinkowska M, Bucki A, Olczyk A, Kołaczkowski M.

Metab Brain Dis. 2015 Dec;30(6):1487-94. doi: 10.1007/s11011-015-9736-3. Epub 2015 Sep 29.

44.

Arylpiperazinylalkyl derivatives of 8-amino-1,3-dimethylpurine-2,6-dione as novel multitarget 5-HT/D receptor agents with potential antipsychotic activity.

Chłoń-Rzepa G, Bucki A, Kołaczkowski M, Partyka A, Jastrzębska-Więsek M, Satała G, Bojarski AJ, Kalinowska-Tłuścik J, Kazek G, Mordyl B, Głuch-Lutwin M, Wesołowska A.

J Enzyme Inhib Med Chem. 2016 Dec;31(6):1048-62. doi: 10.3109/14756366.2015.1088844. Epub 2015 Sep 25.

PMID:
26406608
45.

Antidepressant-like activity of EMD 386088, a 5-HT6 receptor partial agonist, following systemic acute and chronic administration to rats.

Jastrzębska-Więsek M, Siwek A, Partyka A, Szewczyk B, Sowa-Kućma M, Wasik A, Kołaczkowski M, Wesołowska A.

Naunyn Schmiedebergs Arch Pharmacol. 2015 Oct;388(10):1079-88. doi: 10.1007/s00210-015-1141-2. Epub 2015 Jun 16.

PMID:
26077660
46.

Structure-activity relationships and molecular studies of novel arylpiperazinylalkyl purine-2,4-diones and purine-2,4,8-triones with antidepressant and anxiolytic-like activity.

Zagórska A, Kołaczkowski M, Bucki A, Siwek A, Kazek G, Satała G, Bojarski AJ, Partyka A, Wesołowska A, Pawłowski M.

Eur J Med Chem. 2015 Jun 5;97:142-54. doi: 10.1016/j.ejmech.2015.04.046. Epub 2015 May 1.

PMID:
25965777
47.

Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.

Czopek A, Kołaczkowski M, Bucki A, Byrtus H, Pawłowski M, Kazek G, Bojarski AJ, Piaskowska A, Kalinowska-Tłuścik J, Partyka A, Wesołowska A.

Bioorg Med Chem. 2015 Jul 1;23(13):3436-47. doi: 10.1016/j.bmc.2015.04.026. Epub 2015 Apr 16.

PMID:
25936259
48.

New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.

Chłoń-Rzepa G, Zagórska A, Bucki A, Kołaczkowski M, Pawłowski M, Satała G, Bojarski AJ, Partyka A, Wesołowska A, Pękala E, Słoczyńska K.

Arch Pharm (Weinheim). 2015 Apr;348(4):242-53. doi: 10.1002/ardp.201500015. Epub 2015 Mar 13.

PMID:
25773907
49.

Enhanced QSAR models for drug-triggered inhibition of the main cardiac ion currents.

Wiśniowska B, Mendyk A, Szlęk J, Kołaczkowski M, Polak S.

J Appl Toxicol. 2015 Sep;35(9):1030-9. doi: 10.1002/jat.3095. Epub 2015 Jan 5.

PMID:
25559930
50.

Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.

Kołaczkowski M, Marcinkowska M, Bucki A, Śniecikowska J, Pawłowski M, Kazek G, Siwek A, Jastrzębska-Więsek M, Partyka A, Wasik A, Wesołowska A, Mierzejewski P, Bienkowski P.

Eur J Med Chem. 2015 Mar 6;92:221-35. doi: 10.1016/j.ejmech.2014.12.045. Epub 2014 Dec 24.

PMID:
25557493

Supplemental Content

Loading ...
Support Center